Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GenomeDx Biosciences Corp
With
Veracyte, Inc.
Observational study involving the release of tumor genome-wide expression and whole slide imaging data generated by the Decipher assay which will be linked to clinical treatment and outcome data for patients in whom Decipher clinical testing was performed. The GRID database population will be used to characterize the genomics and histopathologic features of cancer and discover or validate gene expression signatures as well as digital pathology models that may be useful for understanding of the biology of the disease and implementing precision medicine approaches for cancer patients.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects that have had a Decipher clinical test
Clareo Health | Decipher Genomics Resource for Intelligent Discovery